A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 39/39 (2006.01) A61K 39/00 (2006.01) A61K 39/106 (2006.01) A61K 39/108 (2006.01) C07K 14/245 (2006.01) A61K 38/00 (2006.01)
Patent
CA 2198586
Methods and compositions are provided herein for the use of a novel mutant form of E. coli heat-labile enterotoxin which has lost its toxicity but has retained its immunologic activity. This enterotoxin is used in combination with an unrelated antigen to achieve an increased immune response to said antigen when adminsitered as part of an oral vaccine preparation.
La présente invention concerne des méthodes et des compositions associées à l'utilisation d'une nouvelle forme mutante de l'entérotoxine thermolabile d'E. coli, laquelle a perdu sa toxicité mais a conservé son activité immunologique. Ladite entérotoxine est utilisée en association avec un antigène non apparenté de façon à induire une réponse immunitaire accrue vis-à-vis dudit antigène lorsqu'elle est administrée dans une préparation vaccinale orale.
Clements John D.
Dickinson Bonny L.
Osler Hoskin & Harcourt Llp
The Administrators Of The Tulane Educational Fund
LandOfFree
Mutant enterotoxin effective as a non-toxic oral adjuvant does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Mutant enterotoxin effective as a non-toxic oral adjuvant, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Mutant enterotoxin effective as a non-toxic oral adjuvant will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1455811